MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/0886022x.2022.2089167

Медицинская библиотека · Renal failure · 2022

Clinical features of children with anti-CFH autoantibody-associated hemolytic uremic syndrome: a report of 8 cases.

Li Qian, Kong Xinxin, Tian Minle, Wang Jing, Yang Zhenle, Yu Lichun, Liu Suwen, Wang Cong, Wang Xiaoyuan, Sun Shuzhen

Клинический случайСтатьяПеревод в очереди

Аннотация

OBJECTIVE

To explore the clinical characteristics, treatment protocol and prognosis of children with anti-complement factor H (CFH) autoantibody (Ab)-associated hemolytic uremic syndrome (HUS).

METHODS

Clinical data of 8 patients with anti-CFH Ab-associated HUS who were admitted to Shandong Provincial Hospital from January 2011 to December 2020 were collected retrospectively.

RESULTS

The age at disease onset ranged between 5.83 and 13.5 years, with a male: female ratio of 1.67:1. The time of onset was distributed from May to June and November to December. Digestive and upper respiratory tract infections were common prodromal infections. Positivity for anti-CFH Ab and reduced C3 levels were observed among all patients. Heterozygous mutation of the CHFR5 gene (c.669del A) and homozygous loss of the CFHR1 gene [loss2(EXON:2-6)] were found in two patients. All patients received early treatment with plasma exchange and corticosteroid therapy. Six patients were given immunosuppressive agents (cyclophosphamide and/or mycophenolate mofetil) for persistent proteinuria. The follow-up period was 12-114 months. Four of 8 patients achieved complete remission, 3 achieved partial remission, and 1 died. Relapse occurred in two patients.

CONCLUSION

Children with anti-CFH Ab-associated HUS were mainly school-aged and predominantly male, with onset times of summer and winter. Digestive and upper respiratory tract infections were common prodromal infections. Plasma exchange combined with methylprednisolone pulse therapy in the acute phase and cyclophosphamide or mycophenolate mofetil treatment for maintenance can be utilized in children with anti-CFH Ab-associated HUS if eculizumab is not available.

Для цитирования: Li Qian, Kong Xinxin, Tian Minle, Wang Jing, Yang Zhenle, Yu Lichun, Liu Suwen, Wang Cong, Wang Xiaoyuan, Sun Shuzhen. Clinical features of children with anti-CFH autoantibody-associated hemolytic uremic syndrome: a report of 8 cases.. Renal failure. 2022. DOI: 10.1080/0886022x.2022.2089167.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.